Juliet Mpendo

机构：International AIDS Vaccine Initiative, Uganda Virus Research Institute · ORCID：0000-0001-8170-9019

发表论文 76 篇 · 总被引 2244 次 · h-index 22

代表论文

• Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial (2022 · The Lancet · 被引 584)
• Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084 (2021 · The Journal of Infectious Diseases · 被引 73)
• Changes in concentrations of cervicovaginal immune mediators across the menstrual cycle: a systematic review and meta-analysis of individual patient data (2022 · BMC Medicine · 被引 26)
• Schistosoma mansoni infection alters the host pre-vaccination environment resulting in blunted Hepatitis B vaccination immune responses (2023 · PLoS neglected tropical diseases · 被引 22)
• Evaluation of long‐acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084 (2025 · Journal of the International AIDS Society · 被引 21)
• Impact of antimicrobials on penile HIV susceptibility and immunology in uncircumcised men: A randomized phase 1/2 clinical trial (2024 · Cell Reports Medicine · 被引 9)